AstraZeneca gains rights to Almirall’s respiratory franchise
As part of the deal, AstraZeneca agreed to pay Almirall about $875m of initial consideration, and up to $1.22bn in development, launch and sales-related milestones. The acquisition gives
Pacira BioSciences has entered into an exclusive agreement with Italian pharmaceutical company Molteni Farmaceutici to distribute and commercialise Exparel across the EU and the UK.
AVP-825 is an investigational drug-device combination product developed by OptiNose which uses OptiNose’s patented Bi-Directional Breath Powered technology to deliver a low dose of sumatriptan powder into the
In addition, the USACC has contracted for clinical evaluation of the VesiculoVax Zaire-Ebola virus vaccine to meet the current outbreak in West Africa. The $9.5 million award has
These waivers are applicable to current or pending New Drug Applications (NDAs) as well as successor products, including those with abuse-deterrent properties and associated labeling claims. In connection